193 related articles for article (PubMed ID: 2414458)
1. Update in cancer chemotherapy, Part III: Lung cancer, Part 1.
Wright JC
J Natl Med Assoc; 1985 Oct; 77(10):815-27. PubMed ID: 2414458
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy in squamous cell carcinoma of the lung.
Krzakowski MJ; Swierz J
Chemioterapia; 1984 Apr; 3(2):75-8. PubMed ID: 6085285
[TBL] [Abstract][Full Text] [Related]
3. The role of chemotherapy in the treatment of lung cancer.
Selawry OS
Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488
[No Abstract] [Full Text] [Related]
4. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
[No Abstract] [Full Text] [Related]
5. [Evaluation of the effects on the composition of alveolar surfactant of 2 chemotherapeutic protocols for carcinoma of the lung: peptichemio and MACC].
Balbi B; Benatti U; Morelli A; Sacco O; Vassallo F; Rossi GA; Ravazzoni C
Ann Ital Med Int; 1987; 2(1):22-30. PubMed ID: 3275275
[No Abstract] [Full Text] [Related]
6. [Recent personal results in advanced bronchial cancer. Palliative immuno-chemotherapy. 63 cases].
Israel L; Depierre A
Ann Med Interne (Paris); 1976 Jan; 127(1):39-42. PubMed ID: 64125
[No Abstract] [Full Text] [Related]
7. [Prognostic factors in the chemotherapy of bronchial cancers].
Alberto P
Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
[No Abstract] [Full Text] [Related]
8. Chemotherapy for lung cancer.
Golbey RB
Postgrad Med; 1978 Feb; 63(2):137-41. PubMed ID: 75540
[TBL] [Abstract][Full Text] [Related]
9. Management of non-small-cell cancer.
Soukop M
Recent Results Cancer Res; 1984; 92():79-88. PubMed ID: 6204364
[No Abstract] [Full Text] [Related]
10. [Antiblastic chemotherapy in esophageal cancer].
Cartei G
Radiol Med; 1983; 69(7-8):597-600. PubMed ID: 6322245
[No Abstract] [Full Text] [Related]
11. Chemotherapy of lung cancer: the experience of the National Cancer Institute of Milan.
Bonadonna G; Tancini G; Bajetta E
Cancer Chemother Rep 3; 1973 Mar; 4(2):231-7. PubMed ID: 4125741
[No Abstract] [Full Text] [Related]
12. [Chemotherapy of lung cancer].
Dement'eva NP
Sov Med; 1984; (11):55-61. PubMed ID: 6084308
[No Abstract] [Full Text] [Related]
13. [Possibilities of adoptive immunochemotherapy in the treatment of non-small-cell lung cancer].
Davydov MI; Normantovich VA; Polotskiĭ BE; Ivshina AV; Mkheidze DM
Vestn Ross Akad Med Nauk; 1996; (3):3-9. PubMed ID: 8672958
[No Abstract] [Full Text] [Related]
14. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR.
Perevodchikova NI; Bychkov MB
Cancer Chemother Rep 3; 1973 Mar; 4(2):251-5. PubMed ID: 4199645
[No Abstract] [Full Text] [Related]
15. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.
Takita H; Marabella PC; Edgerton F; Rizzo D
Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692
[No Abstract] [Full Text] [Related]
16. [Chemotherapy of prostatic cancer].
Portnoĭ AS
Vopr Onkol; 1985; 31(9):3-12. PubMed ID: 2931901
[No Abstract] [Full Text] [Related]
17. [Chemotherapy in bronchogenic carcinoma (author's transl)].
Bruntsch U
Rontgenblatter; 1977 Apr; 30(4):196-201. PubMed ID: 67629
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy of advanced lung cancer: a randomized trial.
Hansen HH; Selawry OS; Simon R; Carr DT; van Wyk CE; Tucker RD; Sealy R
Cancer; 1976 Dec; 38(6):2201-7. PubMed ID: 187312
[TBL] [Abstract][Full Text] [Related]
19. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
[TBL] [Abstract][Full Text] [Related]
20. A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer.
Krook JE; Jett JR; Fleming TR; Dalton RJ; Marschke RF; Cullinan SA; Windschitl HE; Everson LK; Brunk FS; Laurie JA
J Clin Oncol; 1985 Jun; 3(6):842-8. PubMed ID: 3839263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]